Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Arnon Nagler
Busulfan Plus Cyclophosphamide Versus Busulfan Plus Fludarabine as a Preparative Regimen for Allogeneic Haemopoietic Stem-Cell Transplantation in Patients With Acute Myeloid Leukaemia: An Open-Label, Multicentre, Randomised, Phase 3 Trial
The Lancet Oncology
Oncology
Association of Second Allogeneic Hematopoietic Cell Transplant vs Donor Lymphocyte Infusion With Overall Survival in Patients With Acute Myeloid Leukemia Relapse
JAMA Oncology
Cancer Research
Oncology
Higher Doses of Antithymocyte Globulin (ATG) Increase the Risk of Relapse in Acute Myeloid Leukemia (AML) Patients Undergoing Matched Related Donor Allogeneic Transplantation in First Complete Remission (CR1): An Analysis From the Acute Leukemia Working Party of EBMT
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Prognostic Significance of Recurring Chromosomal Abnormalities in Transplanted Patients With Acute Myeloid Leukemia
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Exome Sequencing Identifies Germline Variants in DIS3 in Familial Multiple Myeloma
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Post-Transplant Cyclophosphamide for Graft-Versus-Host Disease Prophylaxis in HLA Matched Sibling or Matched Unrelated Donor Transplant for Patients With Acute Leukemia, on Behalf of ALWP-EBMT
Journal of Hematology and Oncology
Cancer Research
Oncology
Hematology
Molecular Biology
Impact of Conditioning Intensity on Outcomes of Haploidentical Stem Cell Transplantation for Patients With Acute Myeloid Leukemia Over 45 Years of Age
Cancer
Cancer Research
Oncology
Final Overall Survival Results of a Randomized Trial Comparing Bortezomib Plus Pegylated Liposomal Doxorubicin With Bortezomib Alone in Patients With Relapsed or Refractory Multiple Myeloma
Cancer
Cancer Research
Oncology
Inferior Outcome of Allogeneic Stem Cell Transplantation for Secondary Acute Myeloid Leukemia in First Complete Remission as Compared to De Novo Acute Myeloid Leukemia
Blood Cancer Journal
Oncology
Hematology
Outcomes of Hematopoietic Stem Cell Transplantation From Unmanipulated Haploidentical Versus Matched Sibling Donor in Patients With Acute Myeloid Leukemia in First Complete Remission With Intermediate or High-Risk Cytogenetics: A Study From the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Haematologica
Hematology
1
2
3
4
5
›
